Remove 2024 Remove Community Remove Families Remove Family Doctor
article thumbnail

Primary care for all Americans

Common Sense Family Doctor

Don Berwick's dire warning about the existential threat of greed on the failing American health care system seems to be coming true, to the extent that the brazen assassination of an insurance company executive in midtown Manhattan elicited far more outrage about delayed or denied care than sympathy for his family's loss.

article thumbnail

Is there enough time for prevention in primary care?

Common Sense Family Doctor

Family physicians are being squeezed by two accelerating trends: (1) too few of us to care for the growing US population and (2) the rising number of tasks that we are asked to accomplish for each patient. Since 2020, the starting ages for breast, lung, and colorectal cancer screening were lowered to 40, 50, and 45 years, respectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Migraine headaches: diagnostic and treatment tips

Common Sense Family Doctor

An article on acute migraine headaches in the April 2025 issue of American Family Physician reviewed current treatment strategies for acute migraine headaches, which “account for … 3.6 million primary care visits annually and are the fifth most common reason for emergency department visits” in the United States.

article thumbnail

Measles, vaccine hesitancy, and the ACIP

Common Sense Family Doctor

For comparison, there were 285 cases of measles in the United States in 2024, and there have already been more reported cases than in all but two years since 2000. In a 2024 American Family Physician editorial , Dr. Doug Campos-Outcalt reviewed best practices for diagnosis and prevention of measles. since last week.

article thumbnail

Direct-to-consumer advertising distorts prescription drugs’ benefits and costs

Common Sense Family Doctor

In 1998, a Letter to the Editor in American Family Physician expressed concerns about the relatively new practice of pharmaceutical advertising directly to patients. In November 2024, a new U.S.